• Factors ID’d for Strong Antibody Response in COVID-19

    Healthday News COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health October 26, 2020
  • COVID-19 Pandemic Challenges Osteoporosis Management

    Healthday News COVID-19, Family Practice, Geriatrics, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health October 26, 2020
  • AstraZeneca, J&J Resume U.S. COVID-19 Vaccine Trials

    Healthday News COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health, Pharmacy October 26, 2020
  • Survival From COVID-19 High in Patients With Psoriasis

    Healthday News COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, Pharmacy October 23, 2020
  • FDA Needs More Safety Data on COVID-19 Vaccines, Experts Say

    Healthday News COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health, Pharmacy October 23, 2020

Sponsored by Janssen Pharmaceuticals, Inc. Intended for Healthcare Professionals

covid19.healthcare.pro
Navigation
  • COVID-19
  • Latest News
  • Travel Vaccine News
  • Influenza Vaccine News
  • Search
  • COVID-19
  • Latest News
  • Travel Vaccine News
  • Influenza Vaccine News
  • Search
Home DermConnect Example THER

Tag Archive

  • COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health / October 26, 2020

    Factors ID’d for Strong Antibody Response in COVID-19

    View Post
  • COVID-19, Family Practice, Geriatrics, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health / October 26, 2020

    COVID-19 Pandemic Challenges Osteoporosis Management

    View Post
  • COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health, Pharmacy / October 26, 2020

    AstraZeneca, J&J Resume U.S. COVID-19 Vaccine Trials

    View Post
  • COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, Pharmacy / October 23, 2020

    Survival From COVID-19 High in Patients With Psoriasis

    View Post
  • COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health, Pharmacy / October 23, 2020

    FDA Needs More Safety Data on COVID-19 Vaccines, Experts Say

    View Post
View Post

FDA: No Useful Monoclonal Antibody Treatments Left Against New COVID-19 Variants

In COVID-19, Latest News
by Healthday
December 5, 2022

Immunocompromised patients can still receive convalescent plasma

View Post

Adverse Events Mild, Rare With mAb Treatment for COVID-19 in Pregnancy

In COVID-19, Latest News
by Healthday
November 15, 2022

No differences seen in any obstetric-associated outcome or in composite 28-day COVID-19 outcome

Early Use of COVID-19 Convalescent Plasma Cuts Hospitalization Risk

In COVID-19, Latest News
by Healthday
April 1, 2022

Administration of convalescent plasma within nine days after symptom onset can reduce risk of COVID-19-linked hospitalization

View Post

Enhanced External Counterpulsation Eases ‘Long COVID’

In COVID-19, Latest News
by Healthday
February 28, 2022

Improvements seen in symptoms of fatigue, breathing difficulties, 6-minute walk test with EECP treatment

View Post

COVID-19 Convalescent Plasma Seems Safe for High-Risk Children

In COVID-19, Latest News
by Healthday
February 9, 2022

Recipient plasma neutralization titers were 6.2 percent of donor titers as early as 30 minutes after transfusion

View Post

COVID-19 Convalescent Plasma No Benefit for Most Patients

In COVID-19, Latest News
by Healthday
February 3, 2022

No association with clinical outcomes for typical patients; heterogeneity of treatment effect sizes seen across baseline characteristics

View Post

Casirivimab + Imdevimab Prevents Progression to Symptomatic COVID-19

In COVID-19, Latest News
by Healthday
January 26, 2022

For asymptomatic SARS-CoV-2-positive individuals living with infected household contact, combo cuts incidence of symptomatic COVID-19

View Post

Convalescent Plasma Not Efficacious in Hospitalized COVID-19 Patients

In COVID-19, Latest News
by Healthday
December 13, 2021

No significant difference versus placebo observed for hospitalized patients with COVID-19 receiving noninvasive supplemental oxygen

View Post

Convalescent Plasma Not Recommended in COVID-19

In COVID-19, Latest News
by Healthday
December 7, 2021

Guideline Development Group strongly recommends against its use in nonsevere COVID-19, recommends against use in severe, critical illness

View Post

Convalescent Plasma Unlikely to Improve Outcomes in Severe COVID-19

In COVID-19, Latest News
by Healthday
October 14, 2021

Likelihood of improvement in organ support-free days low in critically ill adults with COVID-19 receiving convalescent plasma

  • Page 1 of 3
  • 1
  • 2
  • 3
  • →

TRENDING

  • Pattern of Early Identification of Autism Reversed After Pandemic
  • Tuberculosis Patients Increasing 5% in the U.S.
  • Is Kentucky Protected from Measles
  • 1.9 million Children Receiving Yellow Fever Vaccination
  • More Testing of Staff Linked to Drop in COVID-19 Cases, Deaths at SNFs

By Publish Date

March 2023
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
« Feb    

LATEST ARTICLES

  • Pattern of Early Identification of Autism Reversed After Pandemic March 24, 2023
  • Tuberculosis Patients Increasing 5% in the U.S. March 23, 2023
  • Is Kentucky Protected from Measles March 23, 2023

Sponsored by Janssen Pharmaceuticals, Inc. Intended for U.S. Healthcare Professionals.

Powered by eHealthcare Solutions. | Privacy Policy

  • COVID-19
  • Travel Vaccine News
  • Family Practice
  • OBGYN & Women’s Health
  • Clinical Guidelines